Product Category
Anti-Aging, Telomerase Activators & Pineal Bioregulators
Action on the Human Body
Epitalon (Epithalon) is a synthetic tetrapeptide consisting of the sequence Ala-Glu-Asp-Gly, designed to mimic the active properties of the natural pineal peptide epithalamin. It functions as an epigenetic modifier that directly upregulates telomerase activity, the core enzyme responsible for extending telomere length at chromosome tips. By reversing telomeric shortening in aging cells, Epitalon promotes cellular rejuvenation and delays cellular senescence. Furthermore, it restores normal rhythmicity and output of nighttime melatonin production from the pineal gland, normalizes neuroendocrine sensitivity to hypothalamic feedback loops, lowers systemic oxidative stress, and regulates structural gene expression pathways associated with long-term metabolic health and cancer prevention.
What to Expect if Consumed
Users frequently note a deep correction in sleep quality, enhanced morning vitality, smoother skin elasticity profiles, decreased systemic fatigue, and a general sense of revitalized cellular function.
Possible Therapy Combinations
Pairs excellently with Thymalin (10mg) to form the legendary Khavinson anti-aging bioregulator longevity stack, or layered with GHK-Cu to maximize internal and external cell rejuvenation.
Molecular Formula & Chemical Composition
Sequence: Ala-Glu-Asp-Gly. Molecular Formula: C14H22N4O9. Purity: >99% Pure Lyophilized Powder via precise HPLC verification.
WARNING: This peptide compound must be handled and utilized exclusively under very high, correct professional and qualified medical supervision. Misuse can lead to unintended biological variations.
Scientific References
1. Khavinson, V. Kh., et al. (2003). ‘Peptides elongate telomeres and extend the lifespan of human somatic cells.’ Bulletin of Experimental Biology and Medicine.
2. Anisimov, V. N., et al. (2006). ‘Effect of the peptide Epitalon on life span and spontaneous carcinogenesis in mice.’ Biogerontology.
Reviews
There are no reviews yet.